SAB Biotherapeutics, Inc. (SABSW) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $21.32M | +17.0% |
| 2024 | $18.23M | -31.6% |
| 2023 | $26.64M | +34.2% |
| 2022 | $19.85M | -53.4% |
| 2021 | $42.59M | +143.0% |
| 2020 | $17.53M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $21.32M | +17.0% |
| 2024 | $18.23M | -31.6% |
| 2023 | $26.64M | +34.2% |
| 2022 | $19.85M | -53.4% |
| 2021 | $42.59M | +143.0% |
| 2020 | $17.53M | — |